Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
透过分析师的洞察，揭示ADMA生物制剂的底层原理
6 analysts have shared their evaluations of ADMA Biologics (NASDAQ:ADMA) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三个月中，有6位分析师分享了他们对ADMA Biologics（纳斯达克：ADMA）的评估，表达了看好和看淡的观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $10.58, along with a high estimate of $14.00 and a low estimate of $7.50. This upward trend is evident, with the current average reflecting a 23.31% increase from the previous average price target of $8.58.
在提供更深入的见解方面，分析师们已经制定了12个月的目标价位，表示平均目标价格为10.58美元，最高估价为14.00美元，最低估价为7.50美元。这种上升趋势很明显，当前的平均价格比先前的平均目标价格8.58美元上涨了23.31%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
The...
最...
登录免费看全文
登录/注册